resazurin has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| James, ND; Latham, JP; Mautner, V; Searle, PF | 1 |
| Harada, Y; Hirai, H; Imanishi, J; Iwai, M; Kashima, K; Maruyama-Tabata, H; Mazda, O; Mori, T; Morikawa, T; Muramatsu, A; Okanoue, T; Satoh, E; Tanaka, S | 1 |
2 other study(ies) available for resazurin and Colonic Neoplasms
| Article | Year |
|---|---|
Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Topics: Adenoviridae; Androgens; Antineoplastic Agents; Aziridines; Cell Survival; Colonic Neoplasms; Coloring Agents; Cytomegalovirus; Enhancer Elements, Genetic; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Humans; Jurkat Cells; Kinetics; Luciferases; Luminescent Proteins; Male; Oxazines; Polymerase Chain Reaction; Prodrugs; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Recombinant Fusion Proteins; Tissue Kallikreins; Transfection; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Xanthenes | 2000 |
Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
Topics: beta-Galactosidase; Carcinoembryonic Antigen; Cell Survival; Cholangiocarcinoma; Colonic Neoplasms; Coloring Agents; DNA Primers; Epstein-Barr Virus Nuclear Antigens; Ganciclovir; Genetic Therapy; Genetic Vectors; Humans; Oxazines; Polyamines; Polymerase Chain Reaction; Promoter Regions, Genetic; Transfection; Tumor Cells, Cultured; Xanthenes | 2000 |